The Untold Resilience of PacBio: Can It Sustain Growth Despite Financial Ebb?
PacBio exceeded Wall Street expectations despite a 4.3% decline in year-over-year sales, highlighting its potential resilience and innovation-driven growth. The company’s HiFi long-read sequencing technology, named "method of the year"…